SARS-CoV-2 Infection in Iranian People Living with Human Immunodeficiency Virus-1 Infection

• Published in: Jundishapur journal of microbiology 2022-03, Vol.15 (1)
• Main Authors: Garshasbi, Saba, Bokharaei-Salim, Farah, Khanaliha, Khadijeh, Kiani, Seyed Jalal, Kalantari, Saeed, Jamshidi Makiani, Mahin, Marjani, Arezoo, Dehghani-Dehej, Farzaneh, Babaei, Roghayeh, Sadeghi, Mohsen, Abbasi-Kolli, Mohammad
• Format: Article
• Language: English
• ISSN: 2008-3645; 2008-4161
• DOI: 10.5812/jjm.121929

Background: A novel Coronavirus first emerging in Wuhan, China, was named severe acute respiratory syndrome Coronavirus 2 (SARS‐CoV‐2). The disease caused by SARS‐CoV‐2 is known as Coronavirus disease 2019 (COVID‐19). HIV-1 infected individuals may be at risk of COVID-19. Objectives: This cross-sectional study evaluated the SARS-CoV-2 infection rate and COVID-19 prevalence among Iranian HIV-1-infected people. Methods: The study was conducted on 155 HIV-1-infected patients from June 2020 to October 2020. COVID-19 Ab (IgG) was detected using an enzyme immunoassay in serum specimens. Furthermore, nasopharyngeal and oropharyngeal specimens were collected. Then, the genomic RNA of SARS‐CoV‐2 was detected using a real-time polymerase chain reaction (RT-PCR). Clinical symptoms of the studied participants with and without COVID-19 were examined. Results: Of 155 HIV-1-infected individuals, 12 (7.7%) had positive real-time PCR results for SARS-CoV-2. Out of 12 (7.7%) patients with COVID‐19, four (33.3%) were males. Anti-COVID Ab (IgG) was detected in 10 (6.5%) participants, of whom eight (80.0%) were males. The most common COVID-19 clinical symptoms, including dry cough, fever, runny nose, anosmia, and hypogeusia, were observed in seven (58.3%), five (41.7%), five (41.7%), five (41.7%), and five (41.7%) patients with COVID-19, respectively. Conclusions: A recent study has shown that the risk of SARS‐CoV‐2 infection in HIV-infected individuals is similar to that in the general population.